← All diseases Brain and nervous system

Multiple sclerosis (progressive)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchEvidence of the highest level only (104)Meta-analysis (24)Treatment guideline (1)Randomized trial (43)Systematic review (21)Phase 3 Study (15)Clinical trial (370)Review article (234)Early study (phase 1 or 2) (22)Case report (83)Laboratory or animal study (21)Commentary or editorial (19) Studies currently recruiting participants only (33)

Filter

Publications and studies (1543)

• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Extracellular vesicles in neurodegenerative diseases. (2018/04/01) ♡
• The use of satellite data to measure ultraviolet-B penetrance and its potential association with age of multiple sclerosis onset. (2018/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Evidence for Dietary Interventions and Nutritional Supplements as Treatment Options in Multiple Sclerosis: a Review. (2018/03/17) ♡
• The era of GWAS is over - No. (2018/03/01) ♡
• Systemic sclerosis complicated with localized scleroderma-like lesions induced by Köbner phenomenon. (2018/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Optical coherence tomography in diagnosis and monitoring multiple sclerosis. (2018/03/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Phase II Randomized Controlled Trial of Constraint-Induced Movement Therapy in Multiple Sclerosis. Part 1: Effects on Real-World Function. (2018/03/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Surgical Management of Encapsulating Peritoneal Sclerosis: A Case Report in Kidney Transplant Patient. (2018/02/21) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): Integrating the literature on hereditary diffuse leukoencephalopathy with spheroids (HDLS) and pigmentary orthochromatic leukodystrophy (POLD). (2018/02/01) ♡
• Erratum. (2018/02/01) ♡
• Multiple Sclerosis with Onset Younger Than 10 Years in Turkey. (2018/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Refractory epilepsy following natalizumab associated PML. (2018/02/01) ♡
• Long-term follow-up more than 10 years after HSCT: a monocentric experience. (2018/02/01) ♡
• Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? (2018/02/01) ♡
• Cervical Cord Atrophy and Long-Term Disease Progression in Patients with Primary-Progressive Multiple Sclerosis. (2018/02/01) ♡
• Magnetic resonance imaging findings at the first episode of acute optic neuritis. (2018/02/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Efficacy of computer-based cognitive training in neuropsychological performance of patients with multiple sclerosis: A systematic review and meta-analysis. (2018/02/01) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Disability in progressive MS is associated with T2 lesion changes. (2018/02/01) ♡
• A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease. (2018/01/24) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Persons with secondary progressive and relapsing remitting multiple sclerosis reveal different responses of tryptophan metabolism to acute endurance exercise and training. (2018/01/15) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Vitamin D(3) supplementation and the IL-2/IL-2R pathway in multiple sclerosis: Attenuation of progressive disturbances? (2018/01/15) ♡
• Motor Imagery as a Function of Disease Severity in Multiple Sclerosis: An fMRI Study. (2018/01/11) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. PML in a person with multiple sclerosis: Is teriflunomide the felon? (2018/01/09) ♡
• A 8-year retrospective cohort study comparing Interferon-β formulations for relapsing-remitting multiple sclerosis. (2018/01/01) ♡
• Metabolomics-based discovery of a metabolite that enhances oligodendrocyte maturation. (2018/01/01) ♡
• Longitudinal study of retinal nerve fiber layer thickness changes in a multiple sclerosis patients cohort: A long term 5 year follow-up. (2018/01/01) ♡
• Validation of an algorithm to detect severe MS relapses in administrative health databases. (2018/01/01) ♡
• Plasma exchange in severe acute relapses of multiple sclerosis - Results from a Portuguese cohort. (2018/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Guided Imagery Improves Mood, Fatigue, and Quality of Life in Individuals With Multiple Sclerosis: An Exploratory Efficacy Trial of Healing Light Guided Imagery. (2018/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Thermoregulatory dysfunction in multiple sclerosis. (2018/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeting Voltage-Dependent Calcium Channels with Pregabalin Exerts a Direct Neuroprotective Effect in an Animal Model of Multiple Sclerosis. (2018/01/01) ♡
• Relevance of Helicobacter pylori infection in Egyptian multiple sclerosis patients. (2018/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Invasive Therapies in Multiple Sclerosis. (2018/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immunopathological Factors Associated with Disability in Multiple Sclerosis. (2018/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Relevance of Neuroimaging Findings to Physical Disability in Multiple Sclerosis. (2018/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Masitinib in Primary Progressive Multiple Sclerosis or Relapse-free Secondary Progressive Multiple Sclerosis (2018-12-11) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS) (2018-06-27) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS) (2018-06-26) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Wahls Paleo Diet and Progressive Multiple Sclerosis (2018-06-26) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b (2018-06-21) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Evaluation of the Incidence of Relapses in Patients With Biotin-treated Progressive Multiple Sclerosis (2018-06-11) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis (2018-05-22) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis (2018-05-17) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients (2018-03-22) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Open-label Study of Liothyronine in MS (2018-02-12) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis (2018-01-25) ♡
• Thrombin generation correlates with disease duration in multiple sclerosis (MS): Novel insights into the MS-associated prothrombotic state. (2017/12/26) ♡
• Collaboration between a human group and artificial intelligence can improve prediction of multiple sclerosis course: a proof-of-principle study. (2017/12/22) ♡
• Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic. (2017/12/19) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Effects of Sport Climbing on Multiple Sclerosis. (2017/12/19) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.